Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
06/2003
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/18/2003EP1319658A1 Imidazole derivatives or their salts
06/18/2003EP1318996A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318988A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
06/18/2003EP1318983A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318980A2 Hydroxamate derivatives useful as deacetylase inhibitors
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003EP1255757B1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
06/18/2003EP0757677B1 Benzocyclohexylimidazolethione derivatives
06/17/2003US6580003 Catalytic asymmetric desymmetrization of meso compounds
06/17/2003US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines
06/12/2003WO2003048131A1 Intermediate for biotin and process for producing the same
06/12/2003WO2003048130A2 Peroxisome proliferator activated receptor agonists
06/12/2003WO2003048119A2 Method of producing n-[(2s)-sulfanyl-4-(1,5,5-trimethylhydantoinyl)butanoyl]-l-leucyl-l-tert-leucine n-methylamide and intermediate thereof
06/12/2003WO2003048078A2 Production of ionic liquids
06/12/2003WO2003047740A2 ENANTIOSELECTIVE TRANSFORMATION OF α,β-UNSATURATED KETONES USING CHIRAL ORGANIC CATALYSTS
06/12/2003WO2003047586A1 Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
06/12/2003WO2003047576A1 Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease
06/12/2003WO2003047569A1 Compositions and methods for inhibiting prenyltransferases
06/12/2003WO2003047568A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003US20030109751 Reacting borate with guanidinium or imidazolidinium compound; heating; crystal structure; forming ceramic; fire retarders, microbiocide
06/12/2003US20030109718 Enantioselective transformation of alpha, beta-unsaturated aldehydes using chiral organic catalysts
06/12/2003US20030109609 Thioimidazolidine derivatives as light stabilizers for polymers
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109547 Amidinophenylpyruvic acid derivatives
06/12/2003US20030109497 Novel imidazolidine derivatives, their preparation and their use
06/12/2003US20030109459 Activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
06/12/2003CA2469130A1 Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease
06/12/2003CA2468996A1 Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
06/12/2003CA2468967A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003CA2468846A1 Peroxisome proliferator activated receptor agonists
06/11/2003EP1318140A1 Novel amide derivatives and medicinal use thereof ugs
06/11/2003EP1317433A2 Inhibitors of glycogen synthase kinase 3
06/11/2003EP1317425A2 Resorcinol derivatives
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/11/2003EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
06/11/2003EP0996614B1 Acrylonitrile compounds, process for their production and pesticides containing them
06/11/2003CN1423635A Nitrogenous compounds and antiviral drugs containing the same
06/10/2003US6576780 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
06/10/2003US6576684 Ammonium, phosphonium or sulfonium containing oligomers or polymers; controlled molecular weight, low polydispersity and a vinyl or dienyl end group; polymeric precursors and addi-tives
06/10/2003US6576652 Administering substituted imidazoles, particular by losartan potassium, treatment of post-transplant hypertension.
06/10/2003US6576645 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
06/10/2003US6576614 Administering methyl ketones or closed hemiketal derivatives of aspartic acid
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/10/2003CA2232775C Acyl compounds
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/05/2003WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003WO2003045381A1 Aminoalkylimidazole derivatives and their use in medicine
06/05/2003WO2003045367A1 Angiogenesis inhibitor
06/05/2003WO2003045306A2 Phenoxy amine compounds and compositions for delivering active agents
06/05/2003WO2003004464A3 Heterocyclic amide derivatives and the use thereof as pesticides
06/05/2003WO2002048124A3 Piperazine derivatives
06/05/2003US20030105354 Reaction of corresponding OH, SH or NH compound with an acetylene in liquid phase in presence of basic alkali or alkaline earth metal compounds
06/05/2003US20030105351 Method for producing lysine derivative
06/05/2003US20030105335 Method for producing beta-alaninamides
06/05/2003US20030105331 Use as anorectics, treating obesity and type II diabetes; C2-substituent is a sulfonyl-, sulfinyl- or sulfide-containing group, and indan 1-hydroxy group is esterified, etherified or a carbonate group
06/05/2003US20030105279 Aromatic and heteroaromatic acid halides for synthesizing polyamides
06/05/2003US20030105161 Analgesics; antiinflamamtory agents
06/05/2003US20030105111 For use as fluorescence dyes and probes
06/05/2003US20030105066 For use in producing antiviral, antifungal and antibacterial medicaments
06/05/2003US20030103901 ELISA kit for the determination of CYP2C19 metabolic phenotypes and uses thereof
06/05/2003CA2468716A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/04/2003EP1316543A1 Process for the preparation of aminocarboxylic acids
06/04/2003EP1315697A1 Herbicidal benzoyl cyclohexane dione
06/04/2003EP1049666B1 Novel naphthyl-substituted and anilide-substituted sulfonamides
06/04/2003EP1017679B1 Process for the preparation of imidazoline derivatives
06/04/2003EP0970140B1 Crosslinked polyaspartate salts and a process for their production
06/04/2003EP0964849B1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
06/04/2003EP0882023B1 Histamine h 3 receptor ligands
06/04/2003CN1110484C 2-(cary lphenyl) amino-imidazoline derivatives
06/04/2003CN1110483C Cyclic alkyleneureas containing monomers and polymers and latices therefrom
06/03/2003USRE38132 Phenylpyrrolidines, phenylimidazolidines,3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease
06/03/2003US6573289 Naphthalene derivatives, their production and use
06/03/2003US6573288 Compounds are inhibitors of the sodium-dependent bicarbonate/chloride ion exchanger which can be used as medicines for the prophylaxis or treatment of a wide range of diseases, for example the treatment and/or prophylaxis of
06/03/2003US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
06/03/2003US6573252 Therapy and prevention of bony disorders; improved gastrointestinal tolerability
06/03/2003CA2053954C Process for the preparation of nitroguanidine derivatives
05/2003
05/30/2003WO2003043983A1 Piperazine derivatives destabilising androgen receptors
05/30/2003WO2003043618A2 Amino diols useful in the treatment of alzheimer's disease
05/30/2003WO2003018552A3 Aromatic and heteroaromatic acid halides for synthesizing polyamides
05/30/2003WO2002036116A9 Tripeptidyl peptidase inhibitors
05/30/2003WO2002031025A9 Biodegradable poly(beta-amino esters) and uses thereof
05/30/2003CA2467476A1 Amino diols useful in the treatment of alzheimer's disease
05/29/2003US20030100769 Such s 2-(6-chloro-3-pyridyl)-2-imidazoline which has good affinity for and activate alpha-4-beta-2-nicotinic acetyl-choline receptors; for treatment and prevention of neuro-degenerative disorders (Alzheimer's/Parkinson's disease)
05/29/2003US20030100768 Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors
05/29/2003US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
05/29/2003US20030100750 Process for solid supported synthesis of pyruvate-derived compounds
05/29/2003US20030100593 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses
05/29/2003US20030100586 Agent for controlling animal diseases caused by parasites
05/29/2003US20030100585 For example 3-(2-(1-(2-(3-Methoxy-4-(3-o-tolyl-ureido)-phenyl)-acetylamino )- 3-methyl-butyl)-4,5-dihydro-oxazol-5-yl)-2-methyl-propionic acid
05/29/2003US20030100551 Production of apoptotic films for direct contact with tumors
05/29/2003US20030100494 Containing growth hormone secretion promoting substance for prophylaxis and therapy of diseases involving degeneration or death of nerve cells
05/28/2003EP1313725A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
05/28/2003EP1313724A1 N-heteroarylmethyl-p-phenylendiamine derivatives and compounds containing oxidation colouring agents
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313470A1 Novel alicyclic imidazoles as h 3 agents
05/28/2003CN1109674C Imidazole deriv. and process for preparing same
05/27/2003US6570021 Intermediates for the preparation of 2-imidazolin-5-ones
05/27/2003US6569884 Conformationally rigid bicyclic and adamantane derivatives useful as α2-adrenergic blocking agents